Singapore markets open in 5 hours 19 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,051.76 +16.07 (+0.32%) Dow
38,091.25 +275.33 (+0.73%) Nasdaq
15,744.21 +86.38 (+0.55%) Bitcoin USD
57,273.48 -2,788.40 (-4.64%) CMC Crypto 200
1,216.20 -122.87 (-9.19%)
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:40PM EDT. Market open.
| Previous close | 392.81 |
| Open | 392.81 |
| Bid | 403.64 x 100 |
| Ask | 404.40 x 100 |
| Day's range | 392.47 - 406.90 |
| 52-week range | 320.01 - 448.40 |
| Volume | |
| Avg. volume | 1,131,222 |
| Market cap | 104.403B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 29.06 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Zacks
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
Vertex's (VRTX) revenues in the first quarter of 2024 are likely to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
© 2024 Yahoo. All rights reserved.